Abstract
Following the latest update of cervical cancer screening guidelines in 2012, we estimate the prevalence of guideline adherent cervical cancer screening and examine its associated factors among a nationally representative sample of US women aged 21–65 years. Our study was based on cross-sectional data from Cycles 3 (2013) and 4 (2014) of the Health Information National Trends Survey. The final analytic sample consisted of 2822 women. Guideline adherent cervical cancer screening was defined as having a Pap test within the last 3 years. Correlates of guideline adherent cervical cancer screening included socio-demographic and health-related characteristics and HPV/cervical cancer-related beliefs and knowledge items. Multivariable logistic regression analyses were used to estimate prevalence of guideline adherent screening. An estimated 81.3% of women aged 21–65 years reported being screened for cervical cancer within the last 3 years. Controlling for sociodemographic and health-related characteristics and survey year, women aged 46–65 years were less likely to be guideline adherent than those aged 21–30 years (aPR = 0.89; 95% CI 0.82–0.97). The adjusted prevalence of adherence was significantly higher among married/partnered than among not married women (aPR = 1.13; 95% CI 1.05–1.22), and those with one to three medical visits (aPR = 1.30; 95% CI 1.14–1.48), and four or more visits in the past year (aPR = 1.26; 95% CI 1.09–1.45) compared to those with no medical visits. Differences in unadjusted prevalence of guideline adherent screening depending on women’s beliefs and knowledge about HPV and cervical cancer were not significant in adjusted analyses. Lack of interaction with a healthcare provider, being not married/partnered and increasing age continue to be risk factors of foregoing guideline adherent cervical cancer screening.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
ACOG. (2016). Practice Bulletin No. 157: Cervical cancer screening and prevention. Obstetrics and Gynecology, 127(1), e1–e20. https://doi.org/10.1097/AOG.0000000000001263.
Akers, A. Y., Newmann, S. J., & Smith, J. S. (2007). Factors underlying disparities in cervical cancer incidence, screening, and treatment in the United States. Current Problems in Cancer, 31(3), 157–181. https://doi.org/10.1016/j.currproblcancer.2007.01.001.
Ashok, M., Berkowitz, Z., Hawkins, N. A., Tangka, F., & Saraiya, M. (2012). Recency of Pap testing and future testing plans among women aged 18–64: Analysis of the 2007 Health Information National Trends Survey. Journal of Women’s Health (Larchment), 21(7), 705–712. https://doi.org/10.1089/jwh.2012.3562.
Benard, V. B., Greek, A., Roland, K. B., Hawkins, N. A., Lin, L., & Saraiya, M. (2016). Change in provider beliefs regarding cervical cancer screening intervals after an educational intervention. Journal of Women’s Health (Larchment), 25(5), 422–427. https://doi.org/10.1089/jwh.2015.5706.
Bieler, G. S., Brown, G. G., Williams, R. L., & Brogan, D. J. (2010). Estimating model-adjusted risks, risk differences, and risk ratios from complex survey data. American Journal of Epidemiology, 171(5), 618–623. https://doi.org/10.1093/aje/kwp440.
Castanon, A., Landy, R., Cuzick, J., & Sasieni, P. (2014). Cervical screening at age 50–64 years and the risk of cervical cancer at age 65 years and older: Population-based case control study. PLoS Medicine, 11(1), e1001585. https://doi.org/10.1371/journal.pmed.1001585.
Centers for Disease Control and Prevention. (2015). BRFSS prevalence and trends data. Retrieved September 17, 2017 from https://www.cdc.gov/brfss/brfssprevalence/.
Centers for Disease Control and Prevention. (2017). Cervical cancer statistics. Retrieved September 17, 2017 from https://www.cdc.gov/cancer/cervical/statistics/index.htm.
Cooper, C. P., Saraiya, M., & Sawaya, G. F. (2015). Acceptable and preferred cervical cancer screening intervals among U.S. women. American Journal of Preventive Medicine, 49(6), e99–107. https://doi.org/10.1016/j.amepre.2015.04.025.
Coronado, G. D., Petrik, A., Spofford, M., Talbot, J., Do, H. H., Sanchez, J., et al. (2013). Perceptions of under and overutilization of cervical cancer screening services at Latino-serving community health centers. Journal of Community Health, 38(5), 915–918. https://doi.org/10.1007/s10900-10013-19701-10901.
Cowburn, S., Carlson, M. J., Lapidus, J. A., & DeVoe, J. E. (2013). The association between insurance status and cervical cancer screening in community health centers: Exploring the potential of electronic health records for population-level surveillance, 2008–2010. Preventing Chronic Disease, 10, E173. https://doi.org/10.5888/pcd5810.130034.
Eggleston, K. S., Coker, A. L., Das, I. P., Cordray, S. T., & Luchok, K. J. (2007). Understanding barriers for adherence to follow-up care for abnormal pap tests. Journal of Women’s Health (Larchment), 16(3), 311–330. https://doi.org/10.1089/jwh.2006.0161.
El-Haddad, B., Dong, F., Kallail, K. J., Hines, R. B., & Ablah, E. (2015). Association of marital status and colorectal cancer screening participation in the USA. Colorectal Disease, 17(5), 108–114. https://doi.org/10.1111/codi.12926.
Hanske, J., Meyer, C. P., Sammon, J. D., Choueiri, T. K., Menon, M., Lipsitz, S. R., et al. (2016). The influence of marital status on the use of breast, cervical, and colorectal cancer screening. Preventive Medicine, 89, 140–145. https://doi.org/10.1016/j.ypmed.2016.05.017.
Hirth, J. M., Laz, T. H., Rahman, M., & Berenson, A. B. (2016). Racial/Ethnic differences affecting adherence to cancer screening guidelines among women. Journal of Women’s Health (Larchment), 25(4), 371–380. https://doi.org/10.1089/jwh.2015.5270.
Katz, M. L., Reiter, P. L., Young, G. S., Pennell, M. L., Tatum, C. M., & Paskett, E. D. (2015). Adherence to multiple cancer screening tests among women living in Appalachia Ohio. Cancer Epidemiology, Biomarkers and Prevention, 24(10), 1489–1494. https://doi.org/10.1158/1055-9965.EPI-15-0369.
Kauffman, R. P., Griffin, S. J., Lund, J. D., & Tullar, P. E. (2013). Current recommendations for cervical cancer screening: Do they render the annual pelvic examination obsolete? Medical Principals and Practice, 22(4), 313–322. https://doi.org/10.1159/000346137.
Luque, J. S., Tyson, D. M., Markossian, T., Lee, J. H., Turner, R., Proctor, S., et al. (2011). Increasing cervical cancer screening in a Hispanic migrant farmworker community through faith-based clinical outreach. Journal of Lower Genital Tract Disease, 15(3), 200–204. https://doi.org/10.1097/LGT.1090b1013e318206004a.
Moyer, V. A., & U.S. Preventive Services Task Force. (2012). Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 156(12), 880–891. https://doi.org/10.7326/0003-4819-156-12-201206190-00424.
Nagler, R. H., Lueck, J. A., & Gray, L. S. (2017). Awareness of and reactions to mammography controversy among immigrant women. Health Expectations, 20(4), 638–647. https://doi.org/10.1111/hex.12494.
National Cancer Institute. (2016). Health information national trends survey (HINTS). Retrieved April 7, 2016 from http://hints.cancer.gov.
Nelson, W., Moser, R. P., Gaffey, A., & Waldron, W. (2009). Adherence to cervical cancer screening guidelines for U.S. women aged 25–64: Data from the 2005 Health Information National Trends Survey (HINTS). Journal of Women’s Health (Larchment), 18(11), 1759–1768. https://doi.org/10.1089/jwh.2009.1430.
Ojeaga, A., Alema-Mensah, E., Rivers, D., Azonobi, I., & Rivers, B. (2017). Racial disparities in HPV-related knowledge, attitudes, and beliefs among African American and White women in the USA. Journal of Cancer Education. https://doi.org/10.1007/s13187-017-1268-6.
Rauscher, G. H., Johnson, T. P., Cho, Y. I., & Walk, J. A. (2008). Accuracy of self-reported cancer-screening histories: A meta-analysis. Cancer Epidemiology, Biomarkers and Prevention, 17(4), 748–757. https://doi.org/10.1158/1055-9965.EPI-07-2629.
Roland, K. B., Benard, V. B., Greek, A., Hawkins, N. A., & Lin, L. (2016). Changes in knowledge and beliefs about human papillomavirus and cervical cancer screening intervals in low-income women after an educational intervention. Journal of Primary Care and Community Health, 7(2), 88–95. https://doi.org/10.1177/2150131915624869.
Rositch, A. F., Nowak, R. G., & Gravitt, P. E. (2014). Increased age and race-specific incidence of cervical cancer after correction for hysterectomy prevalence in the United States from 2000 to 2009. Cancer, 120(13), 2032–2038. https://doi.org/10.1002/cncr.28548.
Rosser, J. I., Zakaras, J. M., Hamisi, S., & Huchko, M. J. (2014). Men’s knowledge and attitudes about cervical cancer screening in Kenya. BMC Women’s Health, 14, 138. https://doi.org/10.1186/s12905-014-0138-1.
Sabatino, S. A., White, M. C., Thompson, T. D., Klabunde, C. N., & Centers for Disease, C., & Prevention. (2015). Cancer screening test use—United States, 2013. Morbidity and Mortality Weekly Report, 64(17), 464–468.
Saraiya, M., Berkowitz, Z., Yabroff, K. R., Wideroff, L., Kobrin, S., & Benard, V. (2010). Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: What screening intervals are physicians recommending? Archives of Internal Medicine, 170(11), 977–985. https://doi.org/10.1001/archinternmed.2010.134.
Saslow, D., Solomon, D., Lawson, H. W., Killackey, M., Kulasingam, S. L., Cain, J., et al. (2012). American cancer society, American society for colposcopy and cervical pathology, and American society for clinical pathology screening guidelines for the prevention and early detection of cervical cancer. CA: A Cancer Journal for Clinicians, 62(3), 147–172. https://doi.org/10.3322/caac.21139.
Shoemaker, M. L., & White, M. C. (2016). Breast and cervical cancer screening among Hispanic subgroups in the USA: Estimates from the National Health Interview Survey 2008, 2010, and 2013. Cancer Causes and Control. https://doi.org/10.1007/s10552-016-0718-5.
Smith, J. S., Brewer, N. T., Saslow, D., Alexander, K., Chernofsky, M. R., Crosby, R., et al. (2013). Recommendations for a national agenda to substantially reduce cervical cancer. Cancer Causes and Control, 24(8), 1583–1593. https://doi.org/10.1007/s10552-013-0235-8.
Smith, R. A., Manassaram-Baptiste, D., Brooks, D., Doroshenk, M., Fedewa, S., Saslow, D., et al. (2015). Cancer screening in the United States, 2015: A review of current American Cancer Society guidelines and current issues in cancer screening. CA: A Cancer Journal for Clinicians, 65(1), 30–54. https://doi.org/10.3322/caac.21261.
Spence, A. R., Goggin, P., & Franco, E. L. (2007). Process of care failures in invasive cervical cancer: Systematic review and meta-analysis. Preventive Medicine, 45(2–3), 93–106. https://doi.org/10.1016/j.ypmed.2007.06.007.
Studts, C. R., Tarasenko, Y. N., Schoenberg, N. E., Shelton, B. J., Hatcher-Keller, J., & Dignan, M. B. (2012). A community-based randomized trial of a faith-placed intervention to reduce cervical cancer burden in Appalachia. Preventive Medicine, 54(6), 408–414. https://doi.org/10.1016/j.ypmed.2012.03.019.
Sung, H. Y., Kearney, K. A., Miller, M., Kinney, W., Sawaya, G. F., & Hiatt, R. A. (2000). Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan. Cancer, 88(10), 2283–2289.
U.S. Department of Health and Human Services (2016). Healthy People 2020. Retrieved January 22, 2016 from https://www.healthypeople.gov/2020/topics-objectives/topic/cancer/objectives.
U.S. Preventive Services Task Force. (2012). Cervical cancer: Screening. Retrieved March 8, 2016 from http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/cervical-cancer-screening.
Walsh, B., & O’Neill, C. (2015). Socioeconomic disparities across ethnicities: An application to cervical cancer screening. American Journal of Managed Care, 21(9), e527–e536.
Westat. (2014). Health information national trends survey 4 (HINTS 4) Cycle 3 methodology report. Retrieved April 7, 2016 from http://hints.cancer.gov.
Westat. (2015). Health information national trends survey 4 (HINTS 4) Cycle 4 methodology report. Retrieved April 7, 2016 from http://hints.cancer.gov.
White, M. C., Shoemaker, M. L., & Benard, V. B. (2017). Cervical cancer screening and incidence by age: Unmet needs near and after the stopping age for screening. American Journal of Preventive Medicine, 53(3), 392–395. https://doi.org/10.1016/j.amepre.2017.02.024.
Acknowledgements
Research supported in part by institutional research funding, Hollings Cancer Centers’ Cancer Center Support Grant P30 CA138313 at the Medical University of South Carolina from the National Cancer Institute. The research presented in this paper is that of the authors and does not reflect the official policy of the National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare they have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Luque, J.S., Tarasenko, Y.N. & Chen, C. Correlates of Cervical Cancer Screening Adherence Among Women in the U.S.: Findings from HINTS 2013–2014. J Primary Prevent 39, 329–344 (2018). https://doi.org/10.1007/s10935-018-0513-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10935-018-0513-z